Developing a test which predicts Alzheimer’s disease years in advance.
Enabling prediction, monitoring, diagnosis & successful drug development for Alzheimer’s disease.
Diadem brings together some of the most senior experts from industry and academia to advance a breakthrough in Alzheimer’s disease in the clinic.
Diadem is determined to solve one of the biggest problems in Alzheimer’s disease drug development and patient care: early, accurate, predictive, fast, non-invasive and cost effective diagnosis.
Founded in June 2012, Diadem was born as University of Brescia (Italy)
Spin Off thanks to the support of MIUR.
Diadem focuses on specific research on early peripheral markers of Alzheimer's disease into technology.